ロード中...
Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression
Despite the development of combined modality treatments against liposarcoma (LPS) in recent years, a significant proportion of patients respond only modestly to such approaches, possibly contributing to local or distant recurrence. Early detection of recurrent or metastatic disease could improve pat...
保存先:
| 出版年: | Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033276/ https://ncbi.nlm.nih.gov/pubmed/28588009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-2984 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|